Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT02767804
Brief Title: eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

First Submitted : April 30, 2016
First Submitted that Met QC Criteria : May 9, 2016
First Posted : May 10, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 14, 2022
Last Update Posted : January 31, 2022